Related Experiment Video
Updated: Sep 2, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
Primary retroperitoneal perirenal CIC rearrangement sarcoma: A case report
Junjie Yang1, Hongsheng Liu1, Bin Huang1
1Department of Pathology, The First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang 311200, P.R. China.
This case report details a rare primary retroperitoneal perirenal sarcoma featuring CIC gene rearrangement. Diagnosis involved advanced techniques like fluorescence in situ hybridization (FISH) to identify CIC gene translocation.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Primary retroperitoneal perirenal sarcomas with CIC gene rearrangement are exceptionally rare.
- Understanding the clinical, pathological, and genetic features is crucial for diagnosis and management.
Purpose of the Study:
- To present a case of primary retroperitoneal perirenal CIC rearrangement sarcoma.
- To detail the clinical presentation, pathomorphology, and immunohistochemistry findings.
- To report the detection of CIC gene rupture using fluorescence in situ hybridization (FISH).
Main Methods:
- Histopathological examination of tumor tissue.
- Immunohistochemistry for specific cellular markers.
- Fluorescence in situ hybridization (FISH) to detect CIC gene rearrangement.
Main Results:
- The tumor consisted of small- to medium-sized round blue cells with hyperchromatic nuclei.
- Immunohistochemistry showed scattered CD99 expression.
- FISH confirmed CIC gene fragmentation and translocation.
Conclusions:
- This report highlights a rare sarcoma subtype, emphasizing the diagnostic utility of FISH for CIC gene rearrangement.
- Further research into these rare sarcomas is warranted for improved therapeutic strategies.
More Related Videos
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020